Recent studies have demonstrated a novel pathway where DKK1 binds to its novel receptor CKAP4 and activates the Akt-signaling pathway for cancer progression in lung cancer, pancreatic cancer, and esophageal cancer [70,71]. Here, CKAP4 is linked to pancreatic neoplasm.